SRPT
Sarepta Therapeutics, Inc.Company with tickers: SRPT
CIK
873303
CUSIP
803607100
Shares Outstanding
105,576,222
13F Activity (30d)
259 filings
257 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-12 | Mayo Stephen |
Director | Sell | 7,239 |
| 2026-03-11 | Estepan Ian Michael |
Chief Operating Officer | Tax | 1,097 |
| 2026-03-11 | Rothfuss Cristin |
EVP, General Counsel | Tax | 974 |
| 2026-03-11 | Wong Ryan Ho-Yan |
Chief Financial Officer | Tax | 256 |
| 2026-03-11 | Rodino-Klapac Louise |
President, R&D and Tech Ops | Tax | 948 |
| 2026-03-09 | Rothfuss Cristin |
EVP, General Counsel | Tax | 346 |
| 2026-03-09 | Rodino-Klapac Louise |
President, R&D and Tech Ops | Tax | 895 |
| 2026-03-09 | Estepan Ian Michael |
Chief Operating Officer | Tax | 583 |
| 2026-03-09 | Wong Ryan Ho-Yan |
Chief Financial Officer | Tax | 162 |
| 2026-03-09 | Rodino-Klapac Louise |
President, R&D and Tech Ops | Tax | 504 |
| 2026-03-09 | Estepan Ian Michael |
Chief Operating Officer | Tax | 1,036 |
| 2026-03-09 | Wong Ryan Ho-Yan |
Chief Financial Officer | Tax | 113 |
| 2026-03-09 | Rothfuss Cristin |
EVP, General Counsel | Tax | 484 |
| 2026-03-02 | Estepan Ian Michael |
Chief Operating Officer | Tax | 875 |
| 2026-03-02 | Rothfuss Cristin |
EVP, General Counsel | Tax | 408 |
| 2026-03-02 | Rodino-Klapac Louise |
President, R&D and Tech Ops | Tax | 767 |
| 2026-03-02 | Rodino-Klapac Louise |
President, R&D and Tech Ops | Tax | 3,718 |
| 2026-03-02 | Estepan Ian Michael |
Chief Operating Officer | Tax | 3,301 |
| 2026-03-02 | Wong Ryan Ho-Yan |
Chief Financial Officer | Tax | 450 |
| 2026-03-01 | Estepan Ian Michael |
Chief Operating Officer | Convert | 8,125 |
| 2026-03-01 | Estepan Ian Michael |
Chief Operating Officer | Convert | 8,125 |
| 2026-03-01 | Rodino-Klapac Louise |
President, R&D and Tech Ops | Convert | 8,125 |
| 2026-03-01 | Rodino-Klapac Louise |
President, R&D and Tech Ops | Convert | 8,125 |
| 2026-02-26 | Estepan Ian Michael |
Chief Operating Officer | Convert | 2,069 |
| 2026-02-26 | Estepan Ian Michael |
Chief Operating Officer | Convert | 5,381 |
| 2026-02-26 | Estepan Ian Michael |
Chief Operating Officer | Convert | 5,381 |
| 2026-02-26 | Estepan Ian Michael |
Chief Operating Officer | Convert | 2,069 |
| 2026-02-25 | Estepan Ian Michael |
Chief Operating Officer | Award | 1,875 |
| 2026-02-25 | Rodino-Klapac Louise |
President, R&D and Tech Ops | Award | 1,875 |
| 2026-01-29 | Nicaise Claude |
Director | Convert | 10,500 |
| 2026-01-29 | Nicaise Claude |
Director | Tax | 6,780 |
| 2026-01-29 | Nicaise Claude |
Director | Convert | 10,500 |
| 2026-01-27 | BEHRENS M KATHLEEN |
Director | Other | 10,000 |
| 2026-01-27 | BEHRENS M KATHLEEN |
Director | Tax | 6,494 |
| 2026-01-27 | BEHRENS M KATHLEEN |
Director | Convert | 10,500 |
| 2026-01-27 | BEHRENS M KATHLEEN |
Director | Convert | 10,500 |
| 2025-12-18 | Chambers Michael Andrew |
Director | Award | 0 |
| 2025-12-18 | Chambers Michael Andrew |
Director | Other | 0 |
| 2025-12-16 | Estepan Ian Michael |
Chief Operating Officer | Sell | 13,187 |
| 2025-12-07 | INGRAM DOUGLAS S |
Director | Award | 50,000 |
| 2025-12-07 | INGRAM DOUGLAS S |
Director | Award | 73,001 |
| 2025-12-07 | INGRAM DOUGLAS S |
Director | Award | 50,000 |
| 2025-12-07 | INGRAM DOUGLAS S |
Director | Award | 96,541 |
| 2025-12-07 | INGRAM DOUGLAS S |
Director | Award | 269,542 |
| 2025-12-01 | Wong Ryan Ho-Yan |
Chief Financial Officer | Tax | 78 |
| 2025-12-01 | Wong Ryan Ho-Yan |
Chief Financial Officer | Tax | 80 |
| 2025-11-28 | Rothfuss Cristin |
EVP, General Counsel | Tax | 229 |
| 2025-11-17 | Rodino-Klapac Louise |
President, R&D and Tech Ops | Tax | 4,582 |
| 2025-09-03 | Wong Ryan Ho-Yan |
Chief Financial Officer | Award | 25,000 |
| 2025-09-03 | Rothfuss Cristin |
EVP, General Counsel | Award | 93,875 |
Showing 1–50 of 596 transactions